Impact of Atorvastatin Versus Rosuvastatin on 25 Hydroxy Vitamin D Levels in Patients With Acute Coronary Syndrome

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 152 participants.

Also called NCT06765265

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose supportive care
Phase
Phase 4
Enrolled
  • 152 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06765265
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Pakistan (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06765265. Randomized; no masking; primary purpose supportive care. Start 2025-01-05 (actual); primary completion 2026-01-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Impact of Atorvastatin Versus Rosuvastatin on 25 Hydroxy Vitamin D Levels in Patients With Acute Coronary Syndrome
Condition
Acute Coronary Syndromes
Intervention (Drug)
Rosuvastatin 20 mg/day
Intervention (Drug)
Atorvastatin 40 mg
Lead sponsor
King Edward Medical University (class: other)

Record details

Record id
cardio:ct-nct06765265
Content hash
e92a19c024aaa95f93358b1137f47ddc052555aff5958cf363b575831a307d7d